DCM
Driehaus Capital Management’s Vaxcyte PCVX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.39M | Sell |
73,376
-987,487
| -93% | -$32.1M | 0.02% | 325 |
|
2025
Q1 | $40.1M | Sell |
1,060,863
-105,970
| -9% | -$4M | 0.39% | 78 |
|
2024
Q4 | $95.5M | Sell |
1,166,833
-554,463
| -32% | -$45.4M | 0.79% | 24 |
|
2024
Q3 | $197M | Sell |
1,721,296
-213,451
| -11% | -$24.4M | 1.69% | 5 |
|
2024
Q2 | $146M | Buy |
1,934,747
+66,940
| +4% | +$5.05M | 1.41% | 9 |
|
2024
Q1 | $128M | Buy |
1,867,807
+193,439
| +12% | +$13.2M | 1.27% | 12 |
|
2023
Q4 | $105M | Buy |
1,674,368
+350,484
| +26% | +$22M | 1.27% | 9 |
|
2023
Q3 | $67.5M | Buy |
1,323,884
+134,027
| +11% | +$6.83M | 0.88% | 22 |
|
2023
Q2 | $59.4M | Buy |
1,189,857
+575,951
| +94% | +$28.8M | 0.75% | 26 |
|
2023
Q1 | $23M | Sell |
613,906
-216,889
| -26% | -$8.13M | 0.32% | 99 |
|
2022
Q4 | $39.8M | Buy |
830,795
+247,189
| +42% | +$11.9M | 0.59% | 42 |
|
2022
Q3 | $14M | Buy |
583,606
+35,416
| +6% | +$850K | 0.21% | 146 |
|
2022
Q2 | $11.9M | Buy |
548,190
+458,190
| +509% | +$9.97M | 0.19% | 173 |
|
2022
Q1 | $2.17M | Buy |
+90,000
| New | +$2.17M | 0.03% | 318 |
|